ICI class-specific differences are also evident on pituitary MRI, with CTLA-4 inhibitor-associated hypophysitis more commonly being associated with pituitary enlargement, homogeneous enhancement, and stalk thickening, whereas PD-1/PD-L1 inhibitors rarely demonstrate radiologic pituitary changes [3,29,30]. Here, CTLA4 is linked to hypophysitis.